Jun 2, 2021 Penn State Health Researching Severe Reactions To COVID-19 Vaccines
(Derry Twp., PA) Researchers with Penn State Health are looking for people who haven’t been vaccinated against COVID-19 and have a history of severe allergic reactions. They are looking to find out how to predict who will have a severe reaction and come up with ways to avoid it. Around ten in one-million people who get the COVID-19 vaccine have a severe reaction leading to anaphylaxis.
Getty Images
Hiring managers across industries may struggle to attract and retain talent as an exhausted workforce pivots to post-pandemic life. Among healthcare workers, nurses in particular have reported widespread burnout, with some planning to leave their jobs for other roles outside of direct patient care, or to retire.
Now, health systems are offering steep sign-on bonuses. They’re looking to fill permanent roles as delayed care ramps back up, after relying heavily on expensive travel nurses throughout the pandemic.
Georgia-based Piedmont Healthcare is offering sign-on bonuses of up to $30,000 to attract new nurses to work there, so long as they commit to stay for two years,
First Lady Frances Wolf and Acting Physician General Dr. Denise Johnson led a discussion about the COVID-19 vaccines and reproductive health during a Facebook
Penn State startup aims to improve treatment of hydrocephalus
Normal pressure hydrocephalus is a disease resulting from too much cerebrospinal fluid around the brain. NPH symptoms are often confused with Alzheimer’s disease but in many cases are reversible with the placement of a shunt. The HydroFix shunt developed by Penn State researchers is designed to mitigate the risks associated with the current shunts on the market and provide a durable treatment solution for NPH patients.Image: Penn State
Penn State startup aims to improve treatment of hydrocephalus
May 28, 2021
UNIVERSITY PARK, Pa. Normal pressure hydrocephalus (NPH) is a disease resulting from too much cerebrospinal fluid (CSF) around the brain and affects roughly 750,000 Americans, typically those over 65 years old. Symptoms are often confused with Alzheimer’s disease, but in many cases they are reversible with the placement of a shunt.